KMT Hepatech, Inc. - PhoenixBio Group
Current Promotions
No video available
Get in Touch
About
KMT Hepatech, Inc. is a part of PhoenixBio group since December 1, 2017
KMT Hepatech provides efficient and cost-effective in vivo research services utilizing platform technology of small animal model, the PXB-Mouse®.
The PXB-Mouse® is a chimeric mouse model with humanized liver with stable human hepatocytes engraftment of over 70 per cent.
In addition to in vivo services, KMT Hepatech will expand operations and start production of PXB-Cells® - hepatocytes isolated from a PXB-Mouse® liver.
Due to the expanding interest in the humanized liver mouse model across a wide range of drug development fields, the company now offers services in the following areas:
Infectious diseases, such as Hepatitis C, Hepatitis B and Malaria
Safety toxicity: early assessment of potential hepatotoxicity in in vivo settings prior to first-in-human studies
Characterization of human-type drug and lipoprotein metabolism in in vivo settings prior to first-in-human studies
KMT Hepatech, Inc. owns an international patent portfolio that includes coverage of the uPA chimeric mouse model of HCV infection and on the uPA chimeric mouse for all potential applications including HBV, malaria and studies of toxicity, drug and lipoprotein metabolism.
The PXB-Mouse® and PXB-Cells® are your essential tools for therapeutics and vaccine development.
Keywords
No keywords available
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business